Azilsartan Circadian and Sleep Pressure - the 1st Study

NCT01762501 NA COMPLETED Results posted

To determine the efficacy of Azilsartan 20 mg versus Amlodipine 5 mg oral administration once per day for 8 weeks in patients with grade I or grade II essential hypertension.

Details

Lead sponsor	Sogo Rinsho Médéfi Co., Ltd.
Phase	NA
Status	COMPLETED
Enrolment	957
Start date	2012-12
Completion	2013-12

Conditions

• Hypertension

Interventions

• Azilsartan
• Amlodipine

Primary outcomes

• Change in Nocturnal Systolic Blood Pressure Level — Baseline and 8 weeks
  Change at the end of a treatment period (Week 8) from the beginning point of an observation period \*Nocturnal systolic blood pressure level: the mean value of systolic arterial pressure during night (during sleeping)

Countries

Japan